Archives of Plastic Surgery

Korean Society of Plastic and Reconstructive Surgeons (대한성형외과학회)
권호 표지
DOI QR코드

DOI QR Code

Psychiatric Influences on Hidradenitis Suppurativa: A Call for Help

  • Holly D. Shan (Department of Plastic and Reconstructive Surgery, Georgetown University School of Medicine) ;
  • Samuel S. Huffman (Department of Plastic and Reconstructive Surgery, Georgetown University School of Medicine) ;
  • John D. Bovill (Department of Plastic and Reconstructive Surgery, Georgetown University School of Medicine) ;
  • Zoe K. Haffner (Department of Plastic and Reconstructive Surgery, Georgetown University School of Medicine) ;
  • Parhom Towfighi (Department of Plastic and Reconstructive Surgery, Georgetown University School of Medicine) ;
  • Carol D. Benedict (Department of Rheumatology, MedStar Georgetown University Hospital) ;
  • Karen K. Evans (Department of Plastic and Reconstructive Surgery, MedStar Georgetown University Hospital)
  • Received : 2023.01.03
  • Accepted : 2023.08.26
  • Published : 2024.05.15
Download PDF
⟨ Previous Next ⟩

Abstract

Background Hidradenitis suppurativa (HS) is associated with a high prevalence of psychiatric disorders. However, no studies examine how psychiatric disorders influence surgical and financial outcomes. This study aimed to assess impact of a psychiatric diagnosis on patients treated for HS. Methods Patients with HS were retrospectively identified at a single institution from 2010 to 2021. Cohorts were stratified by the presence of a psychiatric disorder. Demographics, comorbidities, and disease characteristics were collected. Outcomes assessed included the procedural interventions and emergency department (ED) visits. Financial distress was assessed via the COST-FACIT Version 2 survey. Results Out of 138 patients, 40 (29.0%) completed the survey of which 19 (47.5%) had a preexisting psychiatric diagnosis. No demographic differences were found between cohorts. Mean follow-up was 16.1 ± 11.0 months. The psychiatric cohort had a higher median number of surgeries received (7.0 vs. 1.5, p < 0.001), a higher median number of ED visits (1.0 vs. 0, p = 0.006), and a similar hospital length of stay (p = 0.456). The mean COST-FACIT score of the overall study population was 19.2 ± 10.7 (grade 1 financial toxicity). The psych cohort had a lower mean COST-FACIT score (16.8 vs. 21.3, p = 0.092) and reported greater financial hardship (3.3 vs. 1.7, p < 0.001). On multivariate analysis, a psychiatric diagnosis was predictive of lower credit scores, more ED visits, and a higher number of surgeries. Conclusion Preexisting psychiatric conditions in patients with HS are associated with increased health care utilization and surgical intervention with substantial financial distress. Plastic surgeons should be cognizant of such comorbid disorders to facilitate holistic care addressing all patient needs.

Keywords

References

  1. Wolkenstein P, Loundou A, Barrau K, Auquier P, Revuz JQuality of Life Group of the French Society of Dermatology. Quality of life impairment in hidradenitis suppurativa: a study of 61 cases. J Am Acad Dermatol 2007;56(04):621-623 
  2. Dalgard FJ, Gieler U, Tomas-Aragones L, et al. The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries. J Invest Dermatol 2015;135(04):984-991 
  3. Hughes JE, Barraclough BM, Hamblin LG, White JE. Psychiatric symptoms in dermatology patients. Br J Psychiatry 1983;143(01):51-54 
  4. Picardi A, Abeni D, Melchi CF, Puddu P, Pasquini P. Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol 2000;143(05):983-991 
  5. Shlyankevich J, Chen AJ, Kim GE, Kimball AB. Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis. J Am Acad Dermatol 2014;71(06):1144-1150 
  6. National Institute of Mental Health. Any Mood Disorder. Accessed December 19, 2022 at: https://www.nimh.nih.gov/health/statistics/any-mood-disorder 
  7. Phan K, Huo YR, Smith SD. Hidradenitis suppurativa and psychiatric comorbidities, suicides and substance abuse: systematic review and meta-analysis. Ann Transl Med 2020;8(13):821-821 
  8. Gooderham M, Papp K. The psychosocial impact of hidradenitis suppurativa. J Am Acad Dermatol 2015;73(5 Suppl 1)S19-S22 
  9. Matusiak L, Bieniek A, Szepietowski JC. Psychophysical aspects of hidradenitis suppurativa. Acta Derm Venereol 2010;90(03):264-268 
  10. Esmann S, Jemec GBE. Psychosocial impact of hidradenitis suppurativa: a qualitative study. Acta Derm Venereol 2011;91(03):328-332 
  11. Katzman JH, Tahmasbi M, Ghayouri M, Nanjappa S, Li MC, Greene J. Management of severe hidradenitis suppurativa. Cureus 2021;13(02):e13483-e13483 
  12. Koumaki D, Efthymiou O, Bozi E, Katoulis AC. Perspectives on perceived stigma and self-stigma in patients with hidradenitis suppurativa. Clin Cosmet Investig Dermatol 2019;12:785-790 
  13. Garbayo-Salmons P, Romani J, Ferrer de la Fuente C, Pallisera Lloveras A, Lopez-LLunell C, Prat Escayola J. Hidradenitis suppurative: our experience with a surgical case management team. Actas Dermosifiliogr (Engl Ed) 2020;111(05):408-412(English Edition) 
  14. de Souza JA, Yap BJ, Wroblewski K, et al. Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the COmprehensive Score for financial Toxicity (COST). Cancer 2017;123(03):476-484 
  15. Webster K, Cella D, Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. Health Qual Life Outcomes 2003;1:79 
  16. Dar MA, Chauhan R, Sharma KK, Trivedi V, Dhingra S, Murti K. Assessing the reliability and validity of comprehensive score for financial toxicity (COST) among radiation oncology patients in India: a cross-sectional pilot study. Ecancermedicalscience 2021;15:1219 
  17. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62(06):593-602 
  18. Alikhan A, Sayed C, Alavi A, et al. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management. J Am Acad Dermatol 2019;81(01):76-90 
  19. Ingram JR. Hidradenitis suppurativa: pathogenesis, clinical features, and diagnosis. UpToDate. Accessed September 11, 2022 at: https://www.uptodate.com/contents/hidradenitis-suppurativa-pathogenesis-clinical-features-and-diagnosis?search=hidradenitis-suppu-&topicRef=110073&source=see_link 
  20. Maes M. Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 1995;19(01):11-38 
  21. Maes M, Berk M, Goehler L, et al. Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. BMC Med 2012;10(01):66 
  22. Wollina U, Koch A, Heinig B, Kittner T, Nowak A. Acne inversa (Hidradenitis suppurativa): A review with a focus on pathogenesis and treatment. Indian Dermatol Online J 2013;4(01):2-11 
  23. Ching DL, Mughal M, Papas A, Soldin M. Axillary reconstruction for hidradenitis suppurativa with an inner-arm transposition flap creating a brachioplasty effect. Arch Plast Surg 2017;44(03):228-233 
  24. Bocchini SF, Habr-Gama A, Kiss DR, Imperiale AR, Araujo SEA. Gluteal and perianal hidradenitis suppurativa: surgical treatment by wide excision. Dis Colon Rectum 2003;46(07):944-949 
  25. Jemec GBE. Clinical practice. Hidradenitis suppurativa. N Engl J Med 2012;366(02):158-164 
  26. Leiphart P, Kitts S, Sciacca Kirby J. Adherence to over-the-counter antimicrobial washes in hidradenitis suppurativa patients. Dermatology 2019;235(05):440-441 
  27. Kokolakis G, Wolk K, Schneider-Burrus S, et al. Delayed diagnosis of hidradenitis suppurativa and its effect on patients and healthcare system. Dermatology 2020;236(05):421-430 
  28. Neeman E, Ben-Eliyahu S. Surgery and stress promote cancer metastasis: new outlooks on perioperative mediating mechanisms and immune involvement. Brain Behav Immun 2013;30:S32-S40 
  29. Frings VG, Schoffski O, Goebeler M, Presser D. Economic analysis of the costs associated with Hidradenitis suppurativa at a German University Hospital. PLoS ONE 2021;16(08):e0255560 
  30. Tsentemeidou A, Sotiriou E, Ioannides D, Vakirlis E. Hidradenitis suppurativa-related expenditure, a call for awareness: systematic review of literature. J Dtsch Dermatol Ges 2022;20(08):1061-1072 
  31. Kitagawa R, Yasui-Furukori N, Tsushima T, Kaneko S, Fukuda I. Depression increases the length of hospitalization for patients undergoing thoracic surgery: a preliminary study. Psychosomatics 2011;52(05):428-432 
  32. Hauck K, Zhao X. How dangerous is a day in hospital? A model of adverse events and length of stay for medical inpatients. Med Care 2011;49(12):1068-1075 
  33. Kirby JS, Miller JJ, Adams DR, Leslie D. Health care utilization patterns and costs for patients with hidradenitis suppurativa. JAMA Dermatol 2014;150(09):937-944 
  34. Khalsa A, Liu G, Kirby JS. Increased utilization of emergency department and inpatient care by patients with hidradenitis suppurativa. J Am Acad Dermatol 2015;73(04):609-614 
  35. Bouberhan S, Shea M, Kennedy A, et al. Financial toxicity in gynecologic oncology. Gynecol Oncol 2019;154(01):8-12 
  36. Huntington SF, Weiss BM, Vogl DT, et al. Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study. Lancet Haematol 2015;2(10):e408-e416 
  37. Hazell SZ, Fu W, Hu C, et al. Financial toxicity in lung cancer: an assessment of magnitude, perception, and impact on quality of life. Ann Oncol 2020;31(01):96-102 
  38. D'Rummo KA, Miller L, TenNapel MJ, Shen X. Assessing the financial toxicity of radiation oncology patients using the validated comprehensive score for financial toxicity as a patient-reported outcome. Pract Radiat Oncol 2020;10(05):e322-e329 
  39. Houle JN, Collins JM, Schmeiser MD. Flu and finances: influenza outbreaks and loan defaults in US Cities, 2004-2012. Am J Public Health 2015;105(09):e75-e80 
  40. Li Y, Gao J, Enkavi AZ, Zaval L, Weber EU, Johnson EJ. Sound credit scores and financial decisions despite cognitive aging. Proc Natl Acad Sci U S A 2015;112(01):65-69 
  41. Israel S, Caspi A, Belsky DW, et al. Credit scores, cardiovascular disease risk, and human capital. Proc Natl Acad Sci USA 2014;111(48):17087-17092 
  42. Dean LT, Schmitz KH, Frick KD, et al. Consumer credit as a novel marker for economic burden and health after cancer in a diverse population of breast cancer survivors in the USA. J Cancer Surviv 2018;12(03):306-315 
  43. Tzellos T, Yang H, Mu F, Calimlim B, Signorovitch J. Impact of hidradenitis suppurativa on work loss, indirect costs and income. Br J Dermatol 2019;181(01):147-154